Knowledge and Self-Reported Clinical Approaches Regarding Medication-Related Osteonecrosis of the Jaw Among Final-Year Dental Students, General Dentists, and Specialist Dentists: An Exploratory Cross-Sectional Study. [PDF]
Çapar İ, Şeker Ç.
europepmc +1 more source
Naringin and denosumab ameliorate osteoporosis and suppress the aldosterone-MR/SGK1 signaling axis by modulating the bone-kidney interorgan communication in Orchiectomized rats. [PDF]
Xiong S +10 more
europepmc +1 more source
Effects of a single-dose denosumab on glucose and lipid homeostasis in young infertile men. [PDF]
Wriedt EB +7 more
europepmc +1 more source
A Retrospective Cohort Study of Medication-Related Osteonecrosis of the Jaw (MRONJ) Prevention. [PDF]
Baghalipour N +4 more
europepmc +1 more source
MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors. [PDF]
Mammone G +13 more
europepmc +1 more source
Fibrosarcoma of bone masquerading as fibrous dysplasia: diagnostic pitfall and molecular correlates of aggressive behavior. [PDF]
Shi WJ, Huang BK, Lei L.
europepmc +1 more source
Incidental Mandibular FDG Uptake on PET/CT Preceding Medication-Related Osteonecrosis of the Jaw in a Patient Receiving High-Dose Denosumab: A Case Report. [PDF]
Sakamoto Y, Sawada S, Umeda M, Kojima Y.
europepmc +1 more source
Exacerbation of myasthenia gravis after zoledronic acid and denosumab: a novel clinical observation with therapeutic implications. [PDF]
Canneva S +5 more
europepmc +1 more source
Use of low-value cancer care in practices acquired by private equity firms. [PDF]
Mitchell AP +7 more
europepmc +1 more source
Clinical Significance of Bone Turnover Markers in Osteoporosis: Fracture Risk Assessment and Treatment Monitoring. [PDF]
Kim NY, Chung YS, Seo SK.
europepmc +1 more source

